Antibody Platforms

Creative Biolabs offers robust recombinant antibody solutions via its advanced recombinant antibody production platform, utilizing mammalian cells (CHO/HEK293) and an efficient transient transfection system for rapid, high-yield production with batch consistency. Key advantages include animal-free processes, customizable formats (e.g., scFv, bispecifics), and ISO9001-certified quality.

For neutralizing antibody research, the company provides integrated platforms:

• PD-1/PD-L1 Blockade Bioassay Platform for immune checkpoint inhibition assessment.
• Neutralizing Antibody Discovery Platform leveraging single B-cell sorting and high-throughput screening.
• Pseudovirus-based Neutralization Assay Platform for sensitive pathogen-specific neutralization testing.
• Neutralizing Antibody High-throughput Detection Platform enabling multiplexed, rapid antibody validation.

Backed by expertise in infectious disease and immunotherapy, Creative Biolabs delivers tailored, reliable antibody solutions for global researchers.